SKI306X reduced both inflammation and osteoclast differentiation in RA, reducing Th17 cytokine-induced TNFα and IL-1β expression and production in RA synovial fibroblasts during inflammation. This evidence concerns the gene IL1B and rheumatoid arthritis.